RE:RE:RDW on youtube posted todayDJDawg wrote:
Just watched the interview on youtube.
He goes through the whole pre-BTD, BTD thing again. Nothing new.
He mentions other sources of funding that are being explored. Glad to hear him say it aloud (geographic licensing, royalty deals etc). Not sure if that is him being optimistic or hinting at a real effort or dialog that is happening now.
The timeline for FDA full approval he mentions is slow but I think that, given his previous run in with the OSC for being too optimistic and inaccurate about this laser system, he might have to paint the slowest picture possible. IMO
Roger says "the company is also going to be investigating non-dilutive forms of financing into 2024". He did not say discussions are ongoing or they are in advanced negotiations. In the context of what the CoB said 6 months ago ("the company is commencing to actively explore international partnering, licensing and distribution opportunities"), I'd say Roger's choice of very passive language means they are nowhere near any kind of licensing/jv deal. He knows investor interest is waning (just look at the pp closing) and if he had anything substantive to offer on that front he would have said it. So, as a few others have said here, it seems no real partnering discussions or negotiations will transpire prior to a BTD decision imo.
Another back seat driver comment from me is about the recruitment pace. YTD they have enrolled 6 patients, averaging 2 per quarter. Roger wants to wrap things up by end of 24, so 5 quarters to treat 37 patients means averaging about 8 enrollees per quarter, which is an enrollment pace never achieved by this study. Roger sttates, "we are laying in guidelines and direction in order to treat those 37 patients in 2024", which begs an obvious question: if there was a way to guide or direct the CSS's to a more expeditious enrollment rate, why on earth is the company only doing this now? Is this because Roger expects a BTD approval by Q2 24 to hasten recruitment in a big way and leapfrog other trial options?